Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. Social Networks
  10. External Links
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.657466/full, but it redirected us to https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.657466/full. The analysis below is for the second page.

Title[redir]:
Frontiers | m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma
Description:
RNA methylation is a novel epigenetic modification that can be used to evaluate tumor prognosis. However, the underlying mechanisms are unclear. This study a...

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?


Doi.org is built with TYPESETTER CMS.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 76,079,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't tell how the site generates income.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

nsun, lusc, regulators, expression, cancer, cell, tissues, cells, immune, figure, tumor, risk, normal, text, analysis, doi, google, scholar, lung, crossref, full, abstract, database, pubmed, infiltration, prognostic, genes, significantly, found, gene, correlation, patients, tcga, groups, prognosis, rna, study, related, significant, expressed, survival, degree, samples, levels, group, data, score, high, results, mutations,

Topics {✒️}

malat1-mir-1914-3p-yap axis 1and anti-programmed death-lig targeting pi3k/akt/mtor pathway mir-130b–zeb1 axis anti-programmed death-ligand 1 anti-programmed cell death mrna post-transcriptional modification data availability statement important post-transcriptional modification egfr-tyrosine kinase inhibitor lung cancer view small-cell lung cancer open-access article distributed tumor-infiltrating immune cell low-risk subgroups defined nccn guidelines® insights high-throughput sequencing technology including rna export article/supplementary material ten-fold cross-validation protein–protein interactions network cell cycle-related proteins dna damage levels multivariate cox regression rna-seq database focused squamous cell carcinoma post-transcriptional modification high-immune risk group cancer-related deaths worldwide tumor-infiltrating immune cells univariate cox regression cd8+ tumor-infiltrating lymphocytes tumor microenvironment-related cells time-dependent roc analysis fujian medical university tumor-related neutrophil infiltration cell death differ research search frontiers prognostic-related risk values m1a-related regulatory genes single-cell level m5c-related regulatory genes protein–protein interactions single array analysis add chemical modification cell cycle progression prognosis-related risk values inflammatory tumor microenvironment tumor infiltrating lymphocytes include n6-methyladenosine

Schema {🗺️}

ScholarlyArticle:
      context:https://schema.org
      headline:m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma
      author:
            type:Person
            name:Junfan Pan
            affiliation:
               Shengli Clinical Medical College of Fujian Medical University, China
            type:Person
            name:Zhidong Huang
            affiliation:
               Quanzhou First Hospital of Fujian Medical University, China
            type:Person
            name:Yiquan Xu
            affiliation:
               Department of Thoracic Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, China
      datePublished:2021-06-09
      dateModified:2025-07-01
      publisher:
         type:Organization
         name:Frontiers
      isPartOf:
         type:PublicationIssue
         datePublished:2021
         isPartOf:
            type:PublicationVolume
            volumeNumber:11
            isPartOf:
               type:Periodical
               name:Frontiers in Oncology
      citation:
         https://doi.org/10.3389/fonc.2021.657466
      inLanguage:en
Person:
      name:Junfan Pan
      affiliation:
         Shengli Clinical Medical College of Fujian Medical University, China
      name:Zhidong Huang
      affiliation:
         Quanzhou First Hospital of Fujian Medical University, China
      name:Yiquan Xu
      affiliation:
         Department of Thoracic Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, China
Organization:
      name:Frontiers
PublicationIssue:
      datePublished:2021
      isPartOf:
         type:PublicationVolume
         volumeNumber:11
         isPartOf:
            type:Periodical
            name:Frontiers in Oncology
PublicationVolume:
      volumeNumber:11
      isPartOf:
         type:Periodical
         name:Frontiers in Oncology
Periodical:
      name:Frontiers in Oncology

Social Networks {👍}(7)

External Links {🔗}(270)

Libraries {📚}

  • Vue.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cloudflare
  • Crossref

6.06s.